This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Moderate or Severe AD? Improving Assessment of Atopic Dermatitis Severity - The Key to Optimal Treatment

Moderate or Severe AD? Improving Assessment of Atopic Dermatitis Severity - The Key to Optimal Treatment

Format

Slide Lecture Series

Time to Complete

30 minutes

Released

January 25, 2019

Expires

January 24, 2020
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM
0.50 / ABIM MOC Points

All other health care professionals completing this course will be issued a statement of participation.

An important note about ABIM MOC Part II points
Successful completion of this CME activity enables eligible participants to earn up to 0.50 ABIM-Part II Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. To claim MOC points, follow these easy steps:

Step 1: Complete all 3 questions under the "ABIM Part II Credit Questions" section, located at the bottom of the course evaluation form. This includes 1) attesting that our partner may submit your credits to ABIM and that you are Board Certified by the ABIM, 2) providing your ABIM #, full name and your date of birth (MM/DD), 3) attesting that you understand that you must pass the post-test with a score of 80% or higher in order to receive MOC credit.

Step 2: National Jewish Health, will send your MOC points to your ABIM account within 1 month.

Accredited Provider



Provided by National Jewish Health

Commercial Supporter

This activity is supported by an educational grant from Pfizer.

Program Description

This 30-minute program will help optimize treatment of Atopic Dermatitis by improving assessment and appropriate treatment selection for mild to moderate and severe AD. Led by our expert faculty, this interactive, multimedia activity will help improve your ability to manage the treatment of patients with AD. The included diagnostic infographic can be used as an additional diagnosis and treatment tool.

Intended Audience

This activity is designed to meet the educational needs of specialists including allergists and dermatologists. Secondary target audience includes APPs such as NPs and PAs participating in the care of patients with AD.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Identify appropriate assessment tools to distinguish severity of AD based on clinical profiles.
  • Select appropriate treatments for patients with mild-to-moderate AD based on current research, guidelines and mechanisms of action.
  • Select appropriate treatments for patients with severe AD based on current research, guidelines and mechanisms of action.

Conflict Of Interest Disclosure Policy

In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose any significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.

All CME educational activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.

Faculty

Kanwaljit K. Brar, MD (Chair)
Assistant Professor, Pediatrics
National Jewish Health

Dr. Brar has no financial relationships to disclose.

Mark Boguniewicz, MD
Professor, Division of Allergy-Immunology
National Jewish Health

Dr. Boguniewicz discloses that he is a consultant for Lilly, Regeneron and Sanofi Genzyme, an investigator for Regeneron and a speaker for Regeneron and Sanofi Genzyme.

Noreen Heer Nicol, PhD, RN, FNP
Associate Professor
University of Colorado, College of Nursing

Dr. Nicol has no financial relationships to disclose.

Planner and Reviewer Disclosures

Stephanie Corder, ND, RN, has no financial relationships to disclose.
Andrea Harshman, MHA, CHCP, CMP-HC, has no financial relationships to disclose.
Aubrey Shoe, MA, has no financial relationships to disclose.
Christine B. Cho, MD, has no financial relationships to disclose.
Carah B. Santos, MD, has no financial relationships to disclose.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

National Jewish Health designates this live educational activity for a maximum of 0.50 AMA PRA Category 1 CreditTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.

Disclaimer

National Jewish Health ("NJH") and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, "NJH Parties") shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be. By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product. Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Method of Participation

There are no fees for participating and receiving CME credit for this activity. In order to receive credit for this activity, participants must:

  • Read the educational objectives and faculty disclosures.
  • Participate in the online activity.
  • A score of 80% or better on the post-test is required.
  • Complete and submit the evaluation and post-test.
Certificates will be available for download at the end of the activity. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

National Jewish Health, will send your MOC points to your ABIM account within 1 month.

Copyright

© 2018 National Jewish Health. Duplication of this material without authorized permission is prohibited.
Add to Queue